Literature DB >> 18398700

Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc.

Hsin-Chieh Ma1, Ta-Wei Lin, Huichun Li, Sanae M M Iguchi-Ariga, Hiroyoshi Ariga, Yu-Li Chuang, Jing-Hsiung Ou, Shih-Yen Lo.   

Abstract

The ARFP/F protein is synthesized from the +1 reading frame of the hepatitis C virus (HCV) core protein gene. The function of this protein remains unknown. To study the function of the HCV ARFP/F protein, we have conducted the yeast two-hybrid screening experiment to identify cellular proteins that may interact with the ARFP/F protein. MM-1, a c-Myc interacting protein, was found to interact with HCV ARFP/F protein in this experiment. The physical interaction between ARFP/F and MM-1 proteins was further confirmed by the GST pull-down assay, the co-immunoprecipitation assay and confocal microscopy. As MM-1 can inhibit the gene transactivation activity of c-Myc, we have conducted further analysis to examine the possible effect of the ARFP/F protein on c-Myc. Our results indicate that the HCV ARFP/F protein can enhance the gene trans-activation activity of c-Myc, apparently by antagonizing the inhibitory effect of MM-1. The ability of the ARFP/F protein to enhance the activity of c-Myc raises the possibility that ARFP/F protein might play a role in hepatocellular transformation in HCV patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398700     DOI: 10.1007/s11373-008-9248-9

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  17 in total

Review 1.  Hepatitis C virus genetic variability and evolution.

Authors:  Natalia Echeverría; Gonzalo Moratorio; Juan Cristina; Pilar Moreno
Journal:  World J Hepatol       Date:  2015-04-28

2.  Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3).

Authors:  H Qureshi; R Qazi; S Hamid; S A Qureshi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-12       Impact factor: 3.267

3.  Hepatitis C Virus core+1/ARF Protein Modulates the Cyclin D1/pRb Pathway and Promotes Carcinogenesis.

Authors:  Savvina Moustafa; Ioannis Karakasiliotis; Penelope Mavromara
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Cell-mediated immune responses directed against hepatitis C virus (HCV) alternate reading frame protein (ARFP) are undetectable during acute infection.

Authors:  Christian Drouin; Stéphanie Lamarche; Julie Bruneau; Hugo Soudeyns; Naglaa H Shoukry
Journal:  J Clin Virol       Date:  2009-12-01       Impact factor: 3.168

Review 5.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms.

Authors:  Francis J Eng; Jose L Walewski; Arielle L Klepper; Sarah L Fishman; Suresh M Desai; Laura K McMullan; Matthew J Evans; Charles M Rice; Andrea D Branch
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  Ubiquitin-independent degradation of hepatitis C virus F protein.

Authors:  Kamile Yuksek; Wen-Ling Chen; David Chien; Jing-Hsiung James Ou
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

8.  Enterovirus type 71 2A protease functions as a transcriptional activator in yeast.

Authors:  Chee-Hing Yang; Hui-Chun Li; Jeng-Geng Jiang; Che-Fang Hsu; Yi-Jen Wang; Meng-Jiun Lai; Yue-Li Juang; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2010-08-04       Impact factor: 8.410

Review 9.  Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response.

Authors:  Yarden Ariav; James H Ch'ng; Heather R Christofk; Noga Ron-Harel; Ayelet Erez
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

10.  Hepatitis C virus non-structural protein 3 interacts with cytosolic 5'(3')-deoxyribonucleotidase and partially inhibits its activity.

Authors:  Chiu-Ping Fang; Zhi-Cheng Li; Chee-Hing Yang; Ju-Chien Cheng; Yung-Ju Yeh; Tsai-Hsia Sun; Hui-Chun Li; Yue-Li Juang; Shih-Yen Lo
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.